Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects

Benjamin R. Underwood, Chris Fox

Research output: Contribution to journalComment/debatepeer-review

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)181
Number of pages1
JournalBMJ Evidence-Based Medicine
Issue number5
Publication statusPublished - Oct 2014

Cite this